Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-24 @ 2:14 PM
NCT ID:
NCT04398095
Eligibility Criteria:
Inclusion Criteria:
* Able to provide informed consent
* Eastern Cooperative Oncology Group performance status 0 - 2
* Age ≥18 years old
* Histologically-proven diagnosis of radiation-induced or recurrent soft tissue sarcoma
* Previous radiotherapy within the planned target volume
Exclusion Criteria:
* Histologic diagnosis of rhabdomyosarcoma (except spindle cell and pleomorphic subtype), osteogenic sarcoma, Ewing's sarcoma/PNET, aggressive fibromatosis
* Contraindications to radiotherapy or hyperthermia
* Predicted unacceptable high risk of reirradiation-related toxicity, in the Investigator's judgment
* Unresectable metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04398095
Study Brief:
Protocol Section:
NCT04398095